Pharmafile Logo
Pharmafocus logo
Advanced Search

Boehringer agrees Pradaxa kidney function warning

October 30, 2011
Sales and Marketing AF, EMA, Pradaxa, renal function

Boehringer Ingelheim is to alert doctors in Europe of the need to check patients’ kidney function before prescribing anticoagulant Pradaxa. …

News

Dr Reddy’s says two plants clear FDA inspections

October 28, 2011
Manufacturing and Production Dr Reddy's, FDA 483s, India, generics

Two manufacturing facilities operated by Indian drugmaker Dr Reddy’s Laboratories successfully passed inspections by the FDA, although a plant in …

News

Emerging markets help Bayer through tough quarter

October 28, 2011
Sales and Marketing Bayer, Xarelto, emerging markets

Bayer has posted modest results for the third quarter, with growth in emerging markets compensating for austerity measures in Europe …

News
picture_1

PM Society appoints new general manager

October 28, 2011
Medical Communications pm society

The Pharmaceutical Marketing Society has appointed Anneliese Cameron as its new general manager. Anneliese will be joining the Society on …

Appointment

Publicis merges digital agencies into larger group

October 28, 2011
Medical Communications Digitas Health, Razorfish, digital, publicis

Digital agencies Digitas Health and Razorfish Health are to be merged into the larger Publicis Healthcare Communications Group (PHCG).PHCG is …

News

AstraZeneca weathers patent expiry storm

October 27, 2011
Sales and Marketing AstraZeneca, AstraZenecca, q3 2011

 AstraZeneca saw its revenue decline in the third quarter due to an onslaught of patent expiries, but still saw its …

News

Lessons from the world of iPad detailing

October 27, 2011
Medical Communications

This is an article for those who have chosen the iPad as an e-detailing tool. It’s not an argument on …

Feature
Thought Leadership
Social moon image

Alex Butler leaves Janssen to set up Social Moon pharma network

October 27, 2011
Medical Communications Alex Bytler, Jansse, Janssen, comms

Social media guru Alex Butler has left Janssen to establish Social Moon, a digital-only marketing and comms agency for the …

News
Lansley speach

Lansley talks tough on failing hospitals

October 27, 2011
Medical Communications Andrew Lansley, NHS reforms

The health secretary Andrew Lansley says he will intervene to remove management boards of hospitals which can’t clear debts or …

News

Biogen’s MS drug hits phase III targets

October 27, 2011
Sales and Marketing BG-12, Biogen, MS

Biogen’s potential blockbuster MS drug BG-12 has met its primary endpoint in a late-stage trial.   BG-12 (dimethyl fumarate) tablets …

News
GSK logo

GSK sees strong Q3 after battling headwinds

October 27, 2011
Business Services, Sales and Marketing GSK, GSK. Q3, Q3

GlaxoSmithKline has posted a set of healthy figures for the third quarter, underlying its return to growth after a tough …

News
NICE building

Mepact wins NICE backing

October 26, 2011
Research and Development, Sales and Marketing Mepact, NICE

NICE has recommended Takeda’s bone cancer drug Mepact after the firm offered a discount for the treatment. The watchdog’s final …

News

Reforms raise conflicts of interest, say GPs

October 25, 2011
Sales and Marketing BMA, NHS, NHS reforms

Two-thirds of doctors believe that the government’s health reforms will create conflicts of interests in their jobs and undermine their …

News
Novartis HQ

Novartis to cut 2,000 jobs

October 25, 2011
Manufacturing and Production, Research and Development

Novartis will cut around 2,000 jobs is the US and Switzerland as part of additional cost saving measures. The positions …

News

David Meeker appointed as chief executive of Genzyme

October 25, 2011
Research and Development, Sales and Marketing Genzyme, Sanofi

Sanofi has appointed David Meeker as chief executive of its new biotech acquisition Genzyme. He will report to Christopher Viehbacher, …

Appointment

Pharma manufacturing news in brief

October 25, 2011
Manufacturing and Production pharma manufacturing news

Patheon wins a new contract from Boehringer Ingelheim, Ferring buys a UK plant, plus updates from InvaGen, CrossJect and contract …

News

New venture a ‘game-changer’ for pharma

October 25, 2011
Research and Development Sir Christopher Evans, drug development

Sir Christopher Evans is looking to create a new venture that aims to improve on the drug development productivity of …

News
GSK HQ

GSK warned by FDA about Worthing plant

October 25, 2011
Manufacturing and Production

The US FDA has issued a warning letter to GlaxoSmithKline, noting that its manufacturing plant in Worthing, UK, failed to …

News
Sanofi HQ

Sanofi’s Lemtrada beats Rebif in MS study

October 25, 2011
Research and Development, Sales and Marketing Lemtrada, Sanofi

Sanofi’s investigational multiple sclerosis drug Lemtrada has beaten Rebif in a late-stage trial. The Phase III results show that 78% …

News

Flamel secures production contract for GSK heart failure drug

October 25, 2011
Manufacturing and Production Coreg CR, Flamel, GSK, manufacturing

France’s Flamel Technologies has won a long-term contract from GlaxoSmithKline focusing on the production of the drugmaker’s Coreg CR heart …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026